The HK2 converts glucose into glucose 6-phosphate during the first rate limiting step of glycolysis, and its elevated expression has been implicated in promoting tumor growth and invasion (Anderson et al., 2017) as well as developing diabetic glomerulopathy (Isoe et al., 2010). The gene discussed is HK2; the disease is neoplasm.